Seed Round - IDBiologics
Investment Firm
Overview
IDBiologics is a human monoclonal antibodies for the prevention, treatment, and cure of infectious diseases.
Announced Date
May 23, 2023
Funding Type
Seed
Highlights
Location
United States, North America
Social
N/A
Investor Lead
Participant Investors
1
| Investor Name |
|---|
 Vanderbilt University |
Round Details and Background
IDBiologics raised $500000 on 2023-05-23 in Seed Round
IDBiologics is a human monoclonal antibodies for the prevention, treatment, and cure of infectious diseases.
Company Funding History
4
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| May 20, 2020 |  Seed Round - IDBiologics | 1 | - | 4.3M |
| Sep 15, 2021 | Grant - IDBiologics | 1 | - | undefined |
| Dec 26, 2022 | Seed Round - IDBiologics | 1 | - | undefined |
| May 23, 2023 | Seed Round - IDBiologics | 1 | - | 500.0K |
Recent Activity
There is no recent news or activity for this profile.